{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:28:48Z","timestamp":1783484928492,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.4158\/ep11339.cr","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T14:11:31Z","timestamp":1328105491000},"page":"e69-e72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Delayed Antithyroid Drug-Induced Agranulocytosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Priscilla","family":"Mutharasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Oatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau","family":"Kwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Molitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP11339.CR_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose","volume":"98","author":"Cooper","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP11339.CR_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1507\/endocrj.49.29","article-title":"Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis","volume":"49","author":"Dai","year":"2002","journal-title":"Endocr J"},{"key":"10.4158\/EP11339.CR_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(54)90141-2","article-title":"Untoward hematologic responses to the antithyroid compounds","volume":"17","author":"McGavack","year":"1954","journal-title":"Am J Med"},{"key":"10.4158\/EP11339.CR_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03344959","article-title":"Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature","volume":"17","author":"Meyer-Gessner","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP11339.CR_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jama.1946.02870060001001","article-title":"Toxic manifestations of thiouracil therapy","volume":"130","author":"Moore","year":"1946","journal-title":"J Am Med Assoc"},{"key":"10.4158\/EP11339.CR_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1989.tb01424.x","article-title":"Methimazole-induced agranulocytosis in Japanese patients with Graves' disease","volume":"30","author":"Tamai","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP11339.CR_bb0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.7326\/0003-4819-77-3-414","article-title":"Methimazole toxicity from high doses","volume":"77","author":"Wiberg","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP11339.CR_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andr\u00e8s","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.4158\/EP11339.CR_bb0050","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(85)91591-0","article-title":"Antibiotic-induced neutropenia","volume":"2","author":"Murphy","year":"1985","journal-title":"Lancet"},{"key":"10.4158\/EP11339.CR_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.1989.tb07672.x","article-title":"Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies","volume":"72","author":"Salama","year":"1989","journal-title":"Br J Haematol"},{"key":"10.4158\/EP11339.CR_bb0060","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.1977.03280090048022","article-title":"Quinidine-induced agranulocytosis","volume":"238","author":"Eisner","year":"1977","journal-title":"JAMA"},{"key":"10.4158\/EP11339.CR_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-3476(05)81105-9","article-title":"Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis","volume":"117","author":"Watts","year":"1990","journal-title":"J Pediatr"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/81X1623451218211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:54:19Z","timestamp":1761515659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20430526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1530891X20430526"],"URL":"https:\/\/doi.org\/10.4158\/ep11339.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed Antithyroid Drug-Induced Agranulocytosis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP11339.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}